Results 11 to 20 of about 188,184 (297)

A retrospective comparative study of three data modelling techniques in anticoagulation therapy. [PDF]

, 2008
Three types of data modelling technique are applied retrospectively to individual patients’ anticoagulation therapy data to predict their future levels of anticoagulation.
Angelov, Plamen, Xydeas, C., McDonald, Simon   +2 more
core   +5 more sources

Emerging issues in anticoagulation therapy: Examining patient choice, education and adherence [PDF]

, 2017
Anticoagulation therapy is well established, yet as a long-term therapy optimal management of patients can be challenging. The impact of excellent anticoagulation services on population health and reduction of budget pressure is significant, but is ...
Garcia Rangel, Dr Sherezade, LumiraDx Care Solutions   +1 more
core   +7 more sources

Comparison of anticoagulation quality between acenocoumarol and warfarin in patients with mechanical prosthetic heart valves. insights from the nationwide plectrum study [PDF]

, 2021
Vitamin K antagonists are indicated for the thromboprophylaxis in patients with mechanical prosthetic heart valves (MPHV). However, it is unclear whether some differences between acenocoumarol and warfarin in terms of anticoagulation quality do exist. We
Poli D., Cammisotto V., Palareti G., Testa S., The Italian Federation Of Anticoagulation Clinics Fcsa, Menichelli D., Pastori D., Pignatelli P., Antonucci E.   +8 more
core   +1 more source

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR [PDF]

Ann Clin Transl Neurol
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Goicoechea E, Ellsworth P, Siegler J, Brorson J, Lineback C, Conyers F, Kerrigan D, Eklund K, Yaghi S, Khasiyev F, Melkumova E, Culbertson C, D'Souza M, Jillella D, Glover P, Aboul‐Nour H, Nahab F, Shahrivari M, Nedelcu S, Liebeskind D, Smith M, Rothstein A, Bowman A, Zha A, Kala N, Abu Qdais A, Al Kasab S, Farooqui M, Rojas‐Soto D, Aziz Y, Herpich F, Daniel J, Thompson S, Patel V, Nguyen T, Sehgal S, Yu W, Kam W, Van Coevering R, Dumitrascu O, Alvi M, Krishnaiah B, Salehi Omran S, Linares G, Singh E, Ali H, Penckofer M, Thon J, Mannion S, Chahien D, Chen L, Talat F, Abbasi M, Sharma R.   +53 more
europepmc   +2 more sources

Anticoagulants [PDF]

British Medical Bulletin, 2000
Anticoagulation is a treatment with significant and life threatening complications requiring that the balance of risk and benefit be individually assessed in each patient. The risks are greater in the elderly and those with hypertension, falls and gastrointestinal disease.
openaire   +2 more sources

Center-Related Determinants of VKA Anticoagulation Quality: A Prospective, Multicenter Evaluation [PDF]

, 2015
Background: Center-specific TTR (c-TTR) is a measure reporting the mean patient TTR within an anticoagulation clinic describing the quality of anticoagulant monitoring offered by that clinic.
Manotti C, Tosetto A, Italian Federation of Anticoagulation Clinics (FCSA) clinical quality study group, Serino Maria Luisa, Marongiu F   +4 more
core   +2 more sources

Stability of vitamin K antagonist anticoagulation after COVID‐19 diagnosis

Research and Practice in Thrombosis and Haemostasis, 2021
Background Coagulopathy has been reported in severely ill patients with coronavirus disease 2019 (COVID‐19). It is unclear whether outpatients with COVID‐19 who are treated with vitamin K antagonists (VKAs) have unstable anticoagulation.
Eleonora Camilleri, Nienke van Rein, Felix J. M. van der Meer, Melchior C. Nierman, Willem M. Lijfering, Suzanne C. Cannegieter, The Dutch COVID & Thrombosis Coalition   +6 more
doaj   +1 more source

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants

Research and Practice in Thrombosis and Haemostasis, 2022
Lupus anticoagulants (LA) are one laboratory criterion for classification of antiphospholipid syndrome, with presence of vascular thrombosis and/or pregnancy/fetal morbidity being clinical criteria. The presence of LA is detected (or excluded) by laboratory testing, with the activated partial thromboplastin time and dilute Russell's viper venom time ...
Emmanuel J. Favaloro, Leonardo Pasalic
openaire   +3 more sources

Survival Benefit of Anticoagulation Therapy in End Stage Kidney Disease Patients with Atrial Fibrillation: A Single Center Retrospective Study

Medicina, 2021
Background and Objectives: Although the need for anticoagulation to prevent thromboembolism is increasing and non-vitamin K antagonist oral anticoagulants (NOACs) have been tried, there is still controversy about the efficacy of anticoagulation in ...
Mi-Ryung Kim, Deok-Gie Kim, Han-Wul Shin, Sung-Hwa Kim, Jae-Seok Kim, Jae-Won Yang, Byoung-Geun Han, Seong-Ok Choi, Jun Young Lee   +8 more
doaj   +1 more source

Anticoagulants [PDF]

Journal of Pharmacy and Pharmacology, 1949
Abstract The processes that underly the clotting of blood are still far from adequately understood, in spite of the many facts uncovered by generations of patient investigators. The classical scheme associated with the name of Morawitz1, although neither complete nor universally accepted, is still useful as a summary of the main events ...
openaire   +2 more sources